Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Targeting tissue factor as an antithrombotic strategy.

Paolo Golino1, Giovanni Cimmino

  • 1Division of Cardiology, Seconda Università di Napoli, Naples, Italy.

Seminars in Vascular Medicine
|June 17, 2004
PubMed
Summary

Tissue factor (TF) initiates blood clots and is a target for antithrombotic therapies. Inhibiting TF shows promise for treating thrombosis with reduced bleeding risks.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lp(a) as Driver for Lipid Lowering Strategy Optimization in Patients at High and Very-high Risk: beyond LDL-C.

The American journal of cardiology·2026
Same author

Prosthetic Valve Endocarditis by <i>Acinetobacter baumannii:</i> Case Report and Systematic Descriptive Review.

Pathogens (Basel, Switzerland)·2026
Same author

Assessment of Peripheral Arterial (Normal) Flows in Multiple Vascular Territories in Patients Receiving Mechanical Cardiac Support.

Journal of cardiovascular echography·2026
Same author

Mechanical load inhibits cancer growth in mouse and human hearts.

Science (New York, N.Y.)·2026
Same author

Diffuse Cutaneous Systemic Sclerosis Complicated by Serum Amyloid A Protein Cardiac Amyloidosis and Cardiogenic Shock.

CJC open·2026
Same author

Modulation of Cardiometabolic Risk by Vitamin D and K2: Simple Supplementation or Real Drug? Uncovering the Pharmacological Properties.

International journal of molecular sciences·2026

Area of Science:

  • Biochemistry
  • Hematology
  • Vascular Biology

Background:

  • Tissue factor (TF) is a cell-surface protein initiating coagulation and intravascular thrombus formation upon vascular injury or expression in conditions like sepsis and cancer.
  • Beyond hemostasis, TF plays roles in intracellular signaling, cell proliferation, and inflammation, making it a key research focus.
  • TF exposure triggers blood clotting, contributing to pathological processes like thrombosis.

Purpose of the Study:

  • To review the role of tissue factor (TF) in thrombosis and explore therapeutic strategies targeting TF.
  • To evaluate the efficacy and safety of TF inhibition as an antithrombotic intervention.
  • To discuss novel approaches for TF inhibition, including antibodies and genetic strategies.

Main Methods:

  • Review of experimental studies on TF inhibition and its effects on thrombosis and bleeding.
  • Analysis of TF's role in various pathophysiological processes.
  • Exploration of therapeutic strategies targeting TF:factor VIIa activity and TF expression.

Main Results:

  • Inhibition of TF:factor VIIa procoagulant activity effectively inhibits in vivo thrombosis.
  • TF inhibition strategies may lead to less bleeding compared to traditional antithrombotics.
  • Alternative approaches like TF pathway inhibitor or ribozyme transfection offer localized thrombosis inhibition with potentially fewer systemic effects.

Conclusions:

  • TF is a critical target for antithrombotic therapy due to its central role in coagulation.
  • Inhibiting TF offers a promising strategy for managing thrombosis with a potentially favorable safety profile.
  • Further clinical studies are necessary to confirm the efficacy and safety of TF-targeted antithrombotic approaches.

Related Experiment Videos